APA (7th ed.) Citation

Haston, J. C., Hwang, J., & Tan, K. R. (2019). Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019. MMWR: Morbidity & Mortality Weekly Report, 68(46), 1062. https://doi.org/10.15585/mmwr.mm6846a4

Chicago Style (17th ed.) Citation

Haston, Julia C., Jimee Hwang, and Kathrine R. Tan. "Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019." MMWR: Morbidity & Mortality Weekly Report 68, no. 46 (2019): 1062. https://doi.org/10.15585/mmwr.mm6846a4.

MLA (9th ed.) Citation

Haston, Julia C., et al. "Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019." MMWR: Morbidity & Mortality Weekly Report, vol. 68, no. 46, 2019, p. 1062, https://doi.org/10.15585/mmwr.mm6846a4.